These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3237518

  • 1. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
    Berent H, Kancelarczyk WL, Zebrowski M, Uchman B.
    Pol Tyg Lek; 1988 Jun 13; 43(24):776-8. PubMed ID: 3237518
    [No Abstract] [Full Text] [Related]

  • 2. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
    Kuczyńska K, Zebrowski M, Kancelarczyk WL, Rymaszewski Z.
    Pol Tyg Lek; 1988 Aug 22; 43(34):1092-4. PubMed ID: 3075031
    [No Abstract] [Full Text] [Related]

  • 3. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
    Chyzy R, Lukjan H, Rość D, Bielawiec M, Sawicka J.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987 Aug 22; 114(4):549-54. PubMed ID: 2446996
    [Abstract] [Full Text] [Related]

  • 4. [Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
    Beykirch H, Reuter W, Voigt H, Herrmann W.
    Z Gesamte Inn Med; 1989 Feb 01; 44(3):77-9. PubMed ID: 2728555
    [Abstract] [Full Text] [Related]

  • 5. [Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
    Cavaller JM, Samper JC.
    Med Monatsschr; 1976 Jul 01; 30(7):323-6. PubMed ID: 790140
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of vascular diseases of the extremities using pentoxifylline].
    Di Perri T.
    Ric Clin Lab; 1988 Jul 01; 18 Suppl 2():49-56. PubMed ID: 3073515
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
    Strano A, Davì G, Novo S, Avellone G, Pinto A.
    Ric Clin Lab; 1981 Jul 01; 11 Suppl 1():303-11. PubMed ID: 7188117
    [No Abstract] [Full Text] [Related]

  • 8. Fibrinolytic activity and the effects of beta-pyridylcarbinol (Ronicol) in patients with arteriosclerosis obliterans.
    Grodzińska L, Basista M, Kedzior A, Korbut R, Kostka-Trabka E, Gryglewski R.
    Thromb Haemost; 1983 Dec 30; 50(4):797-9. PubMed ID: 6364447
    [Abstract] [Full Text] [Related]

  • 9. [Effect of a single dose of heparin on the fibrinolytic activity of plasma euglobulins and studies on blood coagulation in patients with obliterative arteriosclerosis of the lower extremities].
    Cencora A.
    Folia Med Cracov; 1973 Dec 30; 15(2):207-27. PubMed ID: 4758953
    [No Abstract] [Full Text] [Related]

  • 10. [The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
    Regenthal R, Voigt H, Reuter W, Preiss R.
    Z Gesamte Inn Med; 1991 Apr 30; 46(6):185-90. PubMed ID: 2063598
    [Abstract] [Full Text] [Related]

  • 11. Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action.
    Kostka-Trabkowa E, Dembińska-Kieć A, Grodzińska L, Bieroń K, Gryglewski RJ.
    Curr Med Res Opin; 1985 Apr 30; 9(6):407-15. PubMed ID: 3886306
    [Abstract] [Full Text] [Related]

  • 12. Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysis.
    Ambrus JL, Ambrus CM, Sharma SD, Suh OW, Gastpar H.
    J Med; 1982 Apr 30; 13(5-6):365-71. PubMed ID: 6221055
    [Abstract] [Full Text] [Related]

  • 13. Effects of pentoxifylline and papaverine on tissue perfusion during arterial surgery.
    Niinikoski J, Vänttinen E.
    Acta Chir Scand; 1988 Apr 30; 154(11-12):641-5. PubMed ID: 3232482
    [Abstract] [Full Text] [Related]

  • 14. [Hemocoagulation, fibrinolytic and rheologic parameters in ischemic vasculopathy. Effects of pentoxifylline in the treatment of acute cerebral vasculopathy].
    Muggeo M, Calabrò A, Businaro V, Patussi L, Volpe A, Signorini GP, Crepaldi G.
    Ric Clin Lab; 1981 Apr 30; 11 Suppl 1():353-71. PubMed ID: 7188124
    [No Abstract] [Full Text] [Related]

  • 15. [Status and correction of regional lipid metabolism in atherosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA, Parakhoniak NV, Zubova TA.
    Kardiologiia; 1987 Mar 30; 27(3):77-81. PubMed ID: 2438448
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of various drugs on the dynamics of fibrinolysis in humans].
    Brunetti S, Tesi M.
    Riv Crit Clin Med; 1967 Aug 30; 67(3):233-45. PubMed ID: 5633715
    [No Abstract] [Full Text] [Related]

  • 17. Influence of fibrinolysis activation on leukocyte adhesiveness. Preliminary report.
    Lukjan H, Szpak A, Kwiatkowski M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Aug 30; 113(1-2):191-7. PubMed ID: 2427401
    [Abstract] [Full Text] [Related]

  • 18. [Clinical evaluation of the preparation Trental].
    Wesołowski J, Hubl S, Szubski J, Weinzieher E, Rykowski H.
    Wiad Lek; 1985 Apr 15; 38(8):551-5. PubMed ID: 3892924
    [No Abstract] [Full Text] [Related]

  • 19. [Use of pentoxifylline (trental) to correct microcirculatory disorders in patients with atherosclerosis of peripheral arteries].
    Atroshchenko ES.
    Kardiologiia; 1986 Dec 15; 26(12):106-8. PubMed ID: 3550207
    [No Abstract] [Full Text] [Related]

  • 20. [Evaluation of the clotting system and fibrinolysis after 1-stage novocaine parasciatic blockade in patients with obliterating atherosclerosis of the lower limbs].
    Kempf Z.
    Przegl Lek; 1970 Sep 30; 26(9):735-7. PubMed ID: 5472570
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.